BDP8900
Product Specifications
UNSPSC Description
BDP8900 is a potent and selective inhibitor of myotonic dystrophy-related Cdc42-binding kinases (MRCKα and MRCKβ). BDP8900 reduces substrate phosphorylation, leading to morphological changes, motility inhibition and invasiveness of cancer cells[1].
Target Antigen
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein;MAPK/ERK Pathway
Applications
Cancer-programmed cell death
Field of Research
cancer
Assay Protocol
https://www.medchemexpress.com/bdp8900.html
Smiles
N1(C2=CC=NC3=C2C(C4=NC=CS4)=CN3)C[C@]5(CCCCN5)CCC1
Molecular Weight
353.48
References & Citations
[1]Discovery of potent and selective MRCK inhibitors with therapeutic effect on skin cancer
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-111423/BDP8900-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-111423/
Clinical Information
No Development Reported
CAS Number
2226507-05-5
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
